Genetic approaches against sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) increased fetal hemoglobin and appeared to improve clinical outcomes in 2 small early trials, researchers reported in the New England Journal of Medicine.
PDF的下载单位、IP信息已删除
(2025-6-4)
张欢馨
Criminology34
GingerF
cdercder
woshi123
学术孤儿
ansteel
实验室
dde
可靠铸海
lili
Kao
OK
aajhajkahna
东方元语
梁静茹给我的勇气
迪西
初景
aubusson
YifanWang
皖公网安备34019202002308
